Lung cancer surgery patients have better outcomes at high volume hospitals

July 18, 2001

NEW YORK, July 19, 2001 - Patients with lung cancer live longer if they have surgery at hospitals with experience, according to a study conducted by researchers at Memorial Sloan-Kettering Cancer Center.

The study, published in the July 19 issue of the New England Journal of Medicine, found that patients with lung cancer who undergo lung resection surgery at a hospital that performs larger numbers of the procedures are more likely to survive and have less complications following surgery.

"Our study suggests that there is a significant difference in the quality of care received by patients having surgery for lung cancer," said Peter B. Bach, MD, first author of the study and a pulmonary physician and epidemiologist at Memorial Sloan-Kettering.

"Patients who went to the highest volume hospitals had an 11 percent increased survival rate compared to those patients who went to the lowest volume hospitals. Since approximately 1 in 5 patients diagnosed with lung cancer will have lung resection surgery, it is imperative to identify the possible reasons for the disparity and address it."

Researchers looked at a population based sample of 2118 patients aged 65 years old or older, who lived in one of 10 study areas covered in the Surveillance, Epidemiology and End Results (SEER) Program and who had been diagnosed with stage I, II, or IIIA non-small cell lung cancer between 1985-1996.

Survival rates were examined at 30 days, two years and five years. The average five-year survival for these patients was 38 percent, but patients who went to the highest volume hospitals had a 44 percent five-year survival rate while patients who had the same procedure at the lowest volume hospitals had only a 33 percent five-year survival rate. Complication rates were also twice as high in the lowest volume hospitals, compared to the highest volume hospitals.

"Unfortunately, most hospitals in the U.S. that perform this surgery are low volume hospitals," added Dr. Bach. Of the 76 hospitals in the study 34 performed only 1 to 8 surgeries a year, and 14 performed 9 to 14 surgeries a year. In contrast, only 2 of the hospitals were high volume providers, performing five to ten times as many surgeries (67 to 100 per year).

"The study confirms growing evidence that the quality of cancer surgery is related to the experience of the hospital," said Colin Begg, Ph.D., chairman of the Department of Epidemiology and Biostatistics at Memorial Sloan-Kettering and the paper's senior author. "Major complications of surgery are less likely in hospitals that treat larger numbers of cancer patients, and this translates into lower mortality rates."

Lung cancer is the leading cause of cancer death for men and women in the United States. In the year 2001, it is estimated that there will be 169,500 new cases diagnosed and 157,400 deaths.
-end-
Memorial Sloan-Kettering Cancer Center is the world's oldest and largest institution devoted to prevention, patient care, research and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide.

Memorial Sloan Kettering Cancer Center

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.